A detailed history of American Century Companies Inc transactions in Insmed Inc stock. As of the latest transaction made, American Century Companies Inc holds 723,683 shares of INSM stock, worth $48 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
723,683
Previous 755,271 4.18%
Holding current value
$48 Million
Previous $50.6 Million 4.4%
% of portfolio
0.03%
Previous 0.03%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$62.0 - $79.01 $1.96 Million - $2.5 Million
-31,588 Reduced 4.18%
723,683 $52.8 Million
Q2 2024

Aug 07, 2024

BUY
$22.0 - $69.71 $1.16 Million - $3.67 Million
52,647 Added 7.49%
755,271 $50.6 Million
Q1 2024

May 14, 2024

BUY
$25.72 - $29.94 $1.04 Million - $1.21 Million
40,424 Added 6.1%
702,624 $19.1 Million
Q4 2023

Feb 13, 2024

BUY
$23.42 - $31.74 $15.5 Million - $21 Million
662,200 New
662,200 $20.5 Million
Q3 2023

Nov 13, 2023

BUY
$19.86 - $26.93 $187,458 - $254,192
9,439 Added 1.56%
614,526 $15.5 Million
Q2 2023

Aug 14, 2023

BUY
$16.44 - $21.1 $347,262 - $445,695
21,123 Added 3.62%
605,087 $12.8 Million
Q1 2023

May 11, 2023

SELL
$16.26 - $21.73 $1.2 Million - $1.6 Million
-73,609 Reduced 11.19%
583,964 $9.96 Million
Q4 2022

Feb 13, 2023

BUY
$16.98 - $23.15 $51,364 - $70,028
3,025 Added 0.46%
657,573 $13.1 Million
Q3 2022

Nov 14, 2022

BUY
$20.88 - $28.21 $470,781 - $636,050
22,547 Added 3.57%
654,548 $14.1 Million
Q2 2022

Aug 12, 2022

BUY
$17.07 - $25.71 $731,347 - $1.1 Million
42,844 Added 7.27%
632,001 $12.5 Million
Q1 2022

May 11, 2022

SELL
$20.42 - $28.13 $39,921 - $54,994
-1,955 Reduced 0.33%
589,157 $13.8 Million
Q4 2021

Feb 07, 2022

BUY
$25.89 - $33.45 $1.27 Million - $1.63 Million
48,878 Added 9.01%
591,112 $16.1 Million
Q3 2021

Nov 10, 2021

SELL
$22.46 - $29.47 $247 - $324
-11 Reduced -0.0%
542,234 $14.9 Million
Q2 2021

Aug 05, 2021

BUY
$24.17 - $36.01 $1.58 Million - $2.35 Million
65,377 Added 13.71%
542,245 $15.4 Million
Q1 2021

May 14, 2021

SELL
$32.28 - $44.3 $317,925 - $436,310
-9,849 Reduced 2.02%
476,868 $16.2 Million
Q4 2020

Feb 12, 2021

SELL
$31.45 - $40.54 $148,601 - $191,551
-4,725 Reduced 0.96%
486,717 $16.2 Million
Q3 2020

Nov 13, 2020

BUY
$26.0 - $34.5 $1.21 Million - $1.6 Million
46,436 Added 10.43%
491,442 $15.8 Million
Q2 2020

Aug 13, 2020

BUY
$14.11 - $29.42 $214,994 - $448,272
15,237 Added 3.55%
445,006 $12.3 Million
Q1 2020

May 14, 2020

BUY
$13.63 - $33.98 $78,358 - $195,351
5,749 Added 1.36%
429,769 $6.89 Million
Q4 2019

Feb 12, 2020

BUY
$16.12 - $24.98 $2.72 Million - $4.22 Million
169,044 Added 66.3%
424,020 $10.1 Million
Q3 2019

Nov 13, 2019

BUY
$15.49 - $25.78 $1.66 Million - $2.76 Million
106,950 Added 72.25%
254,976 $4.5 Million
Q2 2019

Aug 14, 2019

BUY
$23.0 - $32.19 $431,158 - $603,433
18,746 Added 14.5%
148,026 $3.79 Million
Q1 2019

May 14, 2019

BUY
$13.91 - $31.15 $1.8 Million - $4.03 Million
129,280 New
129,280 $0
Q4 2018

Feb 13, 2019

SELL
$11.6 - $18.7 $1.48 Million - $2.38 Million
-127,191 Closed
0 $0
Q3 2018

Nov 02, 2018

SELL
$18.95 - $28.08 $17,528 - $25,974
-925 Reduced 0.72%
127,191 $2.57 Million
Q2 2018

Aug 08, 2018

BUY
$20.0 - $29.72 $2.56 Million - $3.81 Million
128,116 New
128,116 $3.03 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $8.98B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.